You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes
|
---|---|
Published in |
New England Journal of Medicine, September 2010
|
DOI | 10.1056/nejmoa1005109 |
Pubmed ID | |
Authors |
Scott D Solomon, Hajime Uno, Eldrin F Lewis, Kai-Uwe Eckardt, Julie Lin, Emmanuel A Burdmann, Dick de Zeeuw, Peter Ivanovich, Andrew S Levey, Patrick Parfrey, Giuseppe Remuzzi, Ajay K Singh, Robert Toto, Fannie Huang, Jerome Rossert, John J V McMurray, Marc A Pfeffer |
Abstract |
Non–placebo-controlled trials of erythropoiesis-stimulating agents (ESAs) comparing lower and higher hemoglobin targets in patients with chronic kidney disease indicate that targeting of a lower hemoglobin range may avoid ESA-associated risks. However, target-based strategies are confounded by each patient's individual hematopoietic response. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | 20% |
United States | 1 | 20% |
Venezuela, Bolivarian Republic of | 1 | 20% |
Unknown | 2 | 40% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 60% |
Practitioners (doctors, other healthcare professionals) | 1 | 20% |
Science communicators (journalists, bloggers, editors) | 1 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 239 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 4 | 2% |
Australia | 3 | 1% |
Japan | 3 | 1% |
Italy | 2 | <1% |
United Kingdom | 1 | <1% |
Uruguay | 1 | <1% |
Korea, Republic of | 1 | <1% |
Denmark | 1 | <1% |
Unknown | 223 | 93% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 49 | 21% |
Other | 31 | 13% |
Student > Ph. D. Student | 26 | 11% |
Student > Bachelor | 25 | 10% |
Professor > Associate Professor | 16 | 7% |
Other | 51 | 21% |
Unknown | 41 | 17% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 134 | 56% |
Agricultural and Biological Sciences | 12 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 11 | 5% |
Nursing and Health Professions | 10 | 4% |
Biochemistry, Genetics and Molecular Biology | 10 | 4% |
Other | 17 | 7% |
Unknown | 45 | 19% |
Attention Score in Context
This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 August 2021.
All research outputs
#1,990,146
of 24,288,533 outputs
Outputs from New England Journal of Medicine
#13,449
of 31,757 outputs
Outputs of similar age
#6,427
of 88,604 outputs
Outputs of similar age from New England Journal of Medicine
#71
of 183 outputs
Altmetric has tracked 24,288,533 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 31,757 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 121.4. This one has gotten more attention than average, scoring higher than 57% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 88,604 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 183 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.